{
    "id": 2655,
    "fullName": "EHMT2 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type EHMT2 indicates that no mutation has been detected within the EHMT2 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10919,
        "geneSymbol": "EHMT2",
        "terms": [
            "EHMT2",
            "BAT8",
            "C6orf30",
            "G9A",
            "GAT8",
            "KMT1C",
            "NG36"
        ]
    },
    "variant": "wild-type",
    "createDate": "11/29/2014",
    "updateDate": "08/24/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1412,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC0638 inhibited the activity of EHMT2, resulting in decreased H3K9me2 levels in several tumor cell lines in culture (PMID: 21743462).",
            "molecularProfile": {
                "id": 2483,
                "profileName": "EHMT2 wild-type"
            },
            "therapy": {
                "id": 1753,
                "therapyName": "UNC0638",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1183,
                    "pubMedId": 21743462,
                    "title": "A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21743462"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 1411,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, UNC0638 inhibited the activity of EHMT2, resulting in decreased H3K9me2 levels and inhibition of growth in breast cancer cells in culture (PMID: 21743462).",
            "molecularProfile": {
                "id": 2483,
                "profileName": "EHMT2 wild-type"
            },
            "therapy": {
                "id": 1753,
                "therapyName": "UNC0638",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1183,
                    "pubMedId": 21743462,
                    "title": "A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21743462"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2483,
            "profileName": "EHMT2 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}